Retatrutide is a synthetic peptide engineered as a single-molecule triple agonist of the GLP-1, GIP, and glucagon receptors. It is a recognised reference compound in incretin and triple-agonist research.
For laboratory research use only. Not for human consumption, therapeutic use, diagnostic application, or veterinary use.
| CAS | 2381089-83-2 |
| Molecular mass | 4731.5 Da |
| Sequence | GLP-1 / GIP / GCG triple agonist (research) |
| Storage | −20°C · desiccated · sealed |